login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
DYNE THERAPEUTICS INC (DYN) Stock News
NASDAQ:DYN - Nasdaq -
US26818M1080
-
Common Stock
- Currency: USD
9.1851
+0.91 (+10.93%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DYN Latest News, Press Relases and Analysis
All
Press Releases
16 days ago - By: Chartmill
- Mentions:
CLRO
AXGN
APDN
NCNA
...
These stocks are moving in today's after hours session
2 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
4 days ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
GM
HTGC
RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT
6 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
9 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
10 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
14 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
14 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
15 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
15 days ago - By: Benzinga
- Mentions:
AVAV
PODD
PRGS
TSLA
...
Tesla, Progress Software, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
15 days ago - By: Benzinga
- Mentions:
BBAI
TZUP
PRGS
MSPR
...
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
16 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
16 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
16 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
16 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
16 days ago - By: Dyne Therapeutics, Inc.
- Mentions:
HTGC
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
16 days ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
16 days ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
18 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
20 days ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
21 days ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
22 days ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
22 days ago - By: Yahoo Finance
- Mentions:
LYFT
EA
HSBC
AVGO
...
Lyft upgraded, Block assumed: Wall Street's top analyst calls
23 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Dyne Therapeutics, Inc. – DYN
24 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
a month ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
a month ago - By: Yahoo Finance
- Mentions:
LLY
Dyne at ‘attractive entry point’ following pullback, says Chardan
a month ago - By: The DJS Law Group
Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – DYN
a month ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
a month ago - By: Dyne Therapeutics, Inc.
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
Please enable JavaScript to continue using this application.